These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32830322)

  • 1. DNA methylation data-based prognosis-subtype distinctions in patients with esophageal carcinoma by bioinformatic studies.
    Chen H; Qin Q; Xu Z; Chen T; Yao X; Xu B; Sun X
    J Cell Physiol; 2021 Mar; 236(3):2126-2138. PubMed ID: 32830322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation data-based molecular subtype classification related to the prognosis of patients with cervical cancer.
    Li C; Ke J; Liu J; Su J
    J Cell Biochem; 2020 Mar; 121(3):2713-2724. PubMed ID: 31680300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CENPE expression is associated with its DNA methylation status in esophageal adenocarcinoma and independently predicts unfavorable overall survival.
    Zhu X; Luo X; Feng G; Huang H; He Y; Ma W; Zhang C; Zeng M; Liu H
    PLoS One; 2019; 14(2):e0207341. PubMed ID: 30716092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer Based on Integrated Analysis.
    Xu Z; Wu Z; Zhang J; Zhou R; Wu J; Yu B
    Biomed Res Int; 2020; 2020():5603958. PubMed ID: 32851080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
    He H; Chen D; Cui S; Wu G; Piao H; Wang X; Ye P; Jin S
    BMC Med Genomics; 2020 Aug; 13(1):118. PubMed ID: 32831081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
    Zhu Q; Tian G; Gao J
    Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns.
    Zhang S; Wang Y; Gu Y; Zhu J; Ci C; Guo Z; Chen C; Wei Y; Lv W; Liu H; Zhang D; Zhang Y
    Mol Oncol; 2018 Jun; 12(7):1047-1060. PubMed ID: 29675884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Autophagy-Related Genes and Small-Molecule Drugs in Esophageal Carcinoma.
    Li Z; Dong K; Guo P; Tan Z; Zhang F; Tian Y; Lv H
    Med Sci Monit; 2020 May; 26():e921855. PubMed ID: 32415055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of molecular targets for esophageal carcinoma diagnosis using miRNA-seq and RNA-seq data from The Cancer Genome Atlas: a study of 187 cases.
    Zeng JH; Xiong DD; Pang YY; Zhang Y; Tang RX; Luo DZ; Chen G
    Oncotarget; 2017 May; 8(22):35681-35699. PubMed ID: 28415685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
    Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
    Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
    Yu XW; She PW; Chen FC; Chen YY; Zhou S; Wang XM; Lin XR; Liu QL; Huang ZJ; Qiu Y
    BMC Cancer; 2024 Feb; 24(1):230. PubMed ID: 38373930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
    Luebeck EG; Curtius K; Hazelton WD; Maden S; Yu M; Thota PN; Patil DT; Chak A; Willis JE; Grady WM
    Clin Epigenetics; 2017; 9():113. PubMed ID: 29046735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal Cancer Epigenomics and Integrome Analysis of Genome-Wide Methylation and Expression in High Risk Northeast Indian Population.
    Singh V; Singh LC; Vasudevan M; Chattopadhyay I; Borthakar BB; Rai AK; Phukan RK; Sharma J; Mahanta J; Kataki AC; Kapur S; Saxena S
    OMICS; 2015 Nov; 19(11):688-99. PubMed ID: 26496483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
    Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
    Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients.
    Shi S; Xu M; Xi Y
    Aging (Albany NY); 2020 Nov; 12(23):23917-23930. PubMed ID: 33237038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
    Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
    Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration in the expression of MGMT and RUNX3 due to non-CpG promoter methylation and their correlation with different risk factors in esophageal cancer patients.
    Saikia S; Rehman AU; Barooah P; Sarmah P; Bhattacharyya M; Deka M; Deka M; Goswami B; Husain SA; Medhi S
    Tumour Biol; 2017 May; 39(5):1010428317701630. PubMed ID: 28468586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
    Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
    Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.